Genuine Biotech (真实生物) Pre-IPO: Challenges Amid Restructuring
Genuine Biotech seeks to raise $100 million through Hong Kong listing with CICC as sole sponsor. Our further look suggest the company is facing...
220 Views
Pre-IPO Genuine Biotech - The Current Pipeline Hardly Supports High Valuation
Genuine's commercialization focuses on azvudine, but long-term valuation should exclude COVID-19 project due to unsustainability. Post money...
252 Views
Genuine Biotech (真实生物) Pre-IPO Tearsheet
Genuine Biotech seeks US$100 million in Hong Kong IPO. We summarize the key facts, including its core products, management and pre-IPO investors...
526 Views
ECM Weekly (24 November 2025) - CATL, Hengrui, Hongqiao, WT Micro, SBI Shinsei, NS Group, Ultragreen
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
326 Views
ECM Weekly (24th Feb 2025) - JX Advance, Mixue, Hexaware, Geekplus, Trualt, Goodman, Xtalpi, Hyundai
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
404 Views